|
Cyclopentamine
|
DB08999 |
[Cyclopentamine is a sympathomimetic alkylamine, classified as a vasoconstrictor. Cyclopentamine was an over the counter treatment for nasal congestion in Europe and Australia. It has been widely discontinued due to the safety, effectiveness, and availability of a similar drug, propylhexedrine.] |
|
3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID
|
DB07668 |
|
|
2,3-DIMETHYL-1,4-NAPHTHOQUINONE
|
DB07669 |
|
|
Apadenoson
|
DB05009 |
[Apadenoson is a selective A2a adenosine receptor agonist designed for use as a pharmacologic stress agent in cardiac perfusion imaging studies. It is developed by Bristol-Myers Squibb and is in phase II of clinical trials.] |
|
Eprazinone
|
DB08990 |
[Eprazinone (trade name Eftapan) is a mucolytic drug, and relieves bronchospasms.] |
|
AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH
|
DB07660 |
|
|
Epirizole
|
DB08991 |
[Epirizole is an oral nonsteroidal anti-inflammatory drug (NSAID) used for muscle and joint pain.] |
|
Eperisone
|
DB08992 |
[Eperisone is an antispasmodic drug which relaxes both skeletal muscles and vascular smooth muscles, and demonstrates a variety of effects such as reduction of myotonia, improvement of circulation, and suppression of the pain reflex. It is not approved for use in the United States, but is available in other countries like India, South Korea, and Bangladesh.] |
|
1,6-DIHYDROXY NAPHTHALENE
|
DB07661 |
|
|
Adecatumumab
|
DB05006 |
[Adecatumumab is a recombinant human monoclonal antibody of the IgG1 subclass with a binding specificity to epithelial cell adhesion molecule (EpCAM). EpCAM (CD326) is a cell surface protein that is frequently expressed at high level on most solid tumor types, including prostate, breast, colon, gastric, ovarian, pancreatic and lung cancer.] |
|
N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
|
DB07662 |
|
|
Enviomycin
|
DB08993 |
[Cyclic basic peptide related to viomycin. It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.] |
|
Elsiglutide
|
DB06336 |
|
|
2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID
|
DB07663 |
|
|
Ditazole
|
DB08994 |
[Ditazole is a non-steroidal anti-inflammatory drug (NSAID). Ditazole's analgesic and antipyretic effects are similar to phenylbutazone. Additionally, ditazole is a platelet aggregation inhibitor marketed in Spain and Portugal with trade name Ageroplas.] |
|
Peptide YY (3-36)
|
DB05004 |
[Peptide YY (3-36), a synthetic human PYY 3-36, is a compound being evaluated for the treatment of obesity. It reduces appetite and increases satiety in obese patients.] |
|
Saxagliptin
|
DB06335 |
[Saxagliptin (rINN) is an orally active hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. FDA approved on July 31, 2009.] |
|
Imexon
|
DB05003 |
[Imexon is currently being studied for the treatment of pancreatic, lung, breast, prostate, melanoma, and multiple myeloma cancers. It belongs to the family of drugs called cyanoaziridine derivatives. Also called Amplimexon. Imexon is a cyanoaziridine derivative.
Imexon is a thiol-binding small molecule which induces mitochondrial oxidation, a loss of membrane potential and cytochrome C, leading to apoptosis.] |
|
Tucidinostat
|
DB06334 |
|
|
5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE
|
DB07664 |
|
